dow jones report has the news.....fed appeal reversed lower court and abt won its appeal. like you,i thought abt would be up and jnj down but the reverse is happening.Perhaps once the news is digested you will see abt move up.
Abbott wins appeal of verdict awarding Johnson & Johnson unit $1.67B The U.S. Supreme Court found that Johnson & Johnson's (JNJ) Centocor unit's patent infringement claims regarding Abbott's (ABT) Humira lack written description. The Court reversed the district court’s ruling and $1.67B award and held the patent claims invalid for failure to meet the statutory written description requirement. :theflyonthewall